MedTrace Logo

A Study of a Urine Test to Detect Colorectal Cancer

NCT07649057 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2026-06-15

No results posted yet for this study

Summary

The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.

Conditions

Interventions

DIAGNOSTIC_TEST

3-metabolite biosensor

3-metabolite biosensor will identify participants with colorectal cancer (CRC) and precancerous polyps

Sponsors & Collaborators

Principal Investigators

  • Peter Kingham, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-11
Primary Completion
2028-06-11
Completion
2028-06-11

Countries

  • United States
  • Ghana
  • South Africa
  • Tanzania

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07649057 on ClinicalTrials.gov